ArticlemedRxiv : the preprint server for health sciences2026
Yellow fever re-emergence in Tolima, Colombia 2024-25: an eco-epidemiological study.
Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Background: Yellow fever virus (YFV) is transmitted by mosquitoes among humans and non-human primates (NHPs) in South America. The 2024-25 yellow fever (YF) outbreak was notable for its spread into new areas, including the department of Tolima in Colombia's Andean region. We investigated the eco-epidemiology of human and NHP YF cases to understand the patterns and drivers of the Tolima outbreak. Methods: We collected spatiotemporal, sociodemographic, and mortality data on human YF cases in Tolima, as well as the locations of deceased NHPs with YF. We then conducted exploratory, descriptive, and spatial statistical analyses to identify risk factors and hotspots for YF. We then used inferential spatiotemporal modelling to compare ecological and sociodemographic drivers. Findings: From September 2024 to October 2025, 116 human and 53 non-human primate YF cases were detected in Tolima. Among the human cases, 77% were male (89/116), and the median age was 47 (interquartile range 34-63). Of these cases, 45 (39%) died, and older age was associated with increased odds of death (adjusted odds ratio, 1.34 per 10 years; 95% confidence interval, 1.10-1.65). There was significant clustering among human and NHP cases. Higher rainfall and poverty/deprivation were associated with increased YF incidence at the neighborhood level, and rainfall during the outbreak was above average due to La Niña. Interpretation: These findings demonstrate significant mortality from YF, which re-emerged in Tolima after nearly a century. Rural populations with greater ecological risk and poverty/deprivation could benefit from targeted vaccination strategies for YF. Funding: National Institutes of Health.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.